Dynavax Technologies Corporation (DVAX)
News
| May 26 | $DVAX Looks like trying to turn around - should get to $4.50 soon now that offering is done - any opinions? by RickPalmer907 |
| May 23 | I'm in $AMRN $ARNA $DVAX (boy that sucks today to be me there) $WCRX (making new HOD for buy out) $BPAX $SIRI (isn't everyone?) $FBC $AAPL by RickPalmer907 |
| May 23 | $DVAX 200 Day SMA Cross - Price crossed below 200 day SMA (3.3889). Confirmed by volume. by TradeIdeasQuant |
| May 23 | $DVAX don't get fooled by downgrading of this company. number of holding increasing from 175 to 190 even after 2 ipo. by poorguy |
| May 23 | $DVAX is holding the ground. close watch for rebound. by poorguy |
| May 23 | $DVAX good news: annual meeting in a week and jeff. global health care conference on June 4-7. going up to $5 soon. by poorguy |
| May 20 | $DVAX Now that the deal is closed I have a feeling we'll see movement to break the 52 wk hi before year end - maybe even within 60 days... by RickPalmer907 |
| May 16 | $AMRN $WRX $DVAX & $FBC my only holdings for now holding cash aside to buy Greece by RickPalmer907 |
| May 14 | Avoid These 2 Plunging Biotechs Fool |
| May 14 | $DVAX in typical fashion - this will move up 1-2% hold for a couple of hours then push over 4% for HOD by RickPalmer907 |
| May 10 | DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Entry into a Material Definitive Agreem... |
| May 10 | UPDATE: Jefferies Lowers PT to $5 on Dynavax Technologies; Commercial Concerns Benzinga |
| May 10 | Company News for May 10, 2012 |
| May 09 | Dynavax shares fall as CEO to leave, issues stock |
Profile
Exchange: NASDAQCM Sector: Healthcare Industry: Drug Manufacturers - Other
1 Year Total Return Performance
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Dynavax Technologies Corporation is up 29.54% over the last year vs S&P 500 Total Return up 1.18%, Isis Pharmaceuticals up 5.16%, and Depomed down 36.38%.
- DVAX Total Returns
- ^SPXTR Total Returns
- ISIS Total Returns
- DEPO Total Returns
Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these DVAX related companies
Pro Strategies Featuring DVAX
Did Dynavax Technologies Corporation make it into our Pro Portfolio Strategies?
DVAX Charts
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Other DVAX Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
- Technical Charts Chart.ly
- Trading Ideas Benzinga
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| DVAX | 3.64 | -0.01 | -0.27% | 567.18M |
| DVA | 81.76 | -0.26 | -0.32% | 7.661B |
| DV | 28.22 | +0.32 | +1.15% | 1.873B |
| DUST | 49.91 | -1.07 | -2.10% | |
| DUSA | 5.44 | +0.04 | +0.74% | 134.10M |
| DUK | 21.96 | +0.16 | +0.73% | 29.38B |
| DUG | 27.46 | +0.20 | +0.73% | |
| DUF | 14.83 | -0.07 | -0.47% | 515.79M |
| DUCK | 8.11 | +0.09 | +1.12% | 31.14M |
| DUC | 12.40 | +0.06 | +0.49% |
